Miwa Haranaka
4PUBLICATIONS
18CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Oct 17, 2024
Pharmacokinetics and Safety of Intravenous Candidate Biosimilar CT-P47 and Reference Tocilizumab: A Randomized, Double-Blind, Phase 1 Study.Miwa Haranaka, Takashi Eto, Takanori Tanaka
|Feb 07, 2023
Pharmacokinetics and safety of CT-P17 (40 mg/0.4 ml) versus reference adalimumab: randomized study in healthy Japanese adults.Miwa Haranaka, Takanori Tanaka, SungHyun Kim
|Dec 15, 2021
A randomized study to evaluate safety and immunogenicity of the BNT162b2 COVID-19 vaccine in healthy Japanese adults.Miwa Haranaka, James Baber, Yoichiro Ogama
|May 13, 2021
A phase I study of high dose camostat mesylate in healthy adults provides a rationale to repurpose the TMPRSS2 inhibitor for the treatment of COVID-19.Junsaku Kitagawa, Hayato Arai, Hiroyuki Iida
Pageof 1
Frequent Collaborators
1 joint publications
Tomohiro Hikima
1 joint publications
Naoto Uemura
1 joint publications
James Baber
1 joint publications
Ingrid Scully
1 joint publications
Ӧzlem Türeci
1 joint publications
Uğur Şahin
1 joint publications
Philip R Dormitzer
1 joint publications
Stephen Lockhart
1 joint publications
Takashi Eto
1 joint publications
Gerd Burmester
